Reserve Bank of Australia President Brock: The policy needs to be carefully considered. Recent data are mixed and somewhat weak.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Australia's S&P/ASX200 index has narrowed its decline and is now down 0.3%.
AUD/USD fell in the short term, and the intraday decline expanded to 0.8%, after the Reserve Bank of Australia announced its interest rate decision.The fund sentiment continues to pick up, and the rebound of A shares is expected to continue! Half-day turnover of Shanghai and Shenzhen 300ETF South (159925) exceeded 90 million yuan. By midday on December 10th, Shanghai and Shenzhen 300ETF South (159925) had increased by 1.83%, with a turnover of 90299400 yuan. Component stocks rose strongly, with China Ping An, China Merchants Bank and Wuliangye rising by over 3%, while Kweichow Moutai, Midea Group and Contemporary Amperex Technology Co., Limited rising by over 2%. In the news, the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on December 9th to analyze and study the economic work in 2025. The meeting stressed that it is necessary to "implement more active and promising macro policies." Galaxy Securities said that looking forward to the market outlook, from the macro event point of view, the US interest rate cut is expected to heat up in December, and the superimposed domestic PMI data performed well. The follow-up policy stimulus and financial data are expected to support the continuous recovery of capital sentiment, which can be appropriately optimistic. In addition, there have been many discussions on the upcoming meeting recently, and there are still strong expectations for stimulus policies. Next, the policy landing will be an important factor affecting whether the market style can be changed. If the fundamentals are expected to improve, the large and medium-sized stocks are expected to change their trend. We can pay attention to the opportunities of medium-term investment, that is, look for the turning point of the industry boom in 2025, such as new energy, medicine, advanced manufacturing, Hong Kong stock Internet and so on.The case of 2024 New Quality Productivity Empowering High Quality Development was released. On December 10th, 2024 China Brand Forum New Quality Productivity Empowering High Quality Development Forum was held in Zhengzhou. At the meeting, the case of high-quality development of new quality productivity in 2024 was released, and 20 enterprises including China Railway Equipment, BYD, Yutong Group, Chihiro Location and Ubisoft Technology were selected. (Dahe Finance Cube)
Australia's S&P/ASX 200 index closed at 8399.40 points, down 0.28%.Treasury futures closed in early trading, with 2-year Treasury futures (TS) up 0.14%, 5-year Treasury futures (TF) up 0.42%, 10-year Treasury futures (T) up 0.64% and 30-year Treasury futures (TL) up 1.23%.Sources: Boeing restarted the production of 737 MAX last week. Sources said that about one month after the strike ended, Boeing restarted the production of 737 MAX aircraft last week.
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13